vanutide cridificar
consists of an N-terminal fragment of amyloid beta-peptide and cross reacting material 197
Networked: 6
relevant articles (0 outcomes,
6 trials/studies)
Bio-Agent Context: Research Results
Experts
| 1. | Ryan, J Michael:
3 articles
(01/2017 - 01/2009)
|
| 2. | Arai, Heii:
2 articles
(01/2017 - 01/2015)
|
| 3. | Holstein, Ann:
2 articles
(01/2017 - 01/2016)
|
| 4. | Ketter, Nzeera:
2 articles
(01/2017 - 01/2016)
|
| 5. | Liu, Enchi:
2 articles
(01/2017 - 01/2016)
|
| 6. | Peng, Yahong:
2 articles
(01/2017 - 01/2016)
|
| 7. | Sadowsky, Carl:
2 articles
(01/2017 - 01/2016)
|
| 8. | Suzuki, Hideo:
2 articles
(01/2017 - 01/2015)
|
| 9. | Yoshiyama, Tamotsu:
2 articles
(01/2017 - 01/2015)
|
| 10. | Ketter, N:
2 articles
(01/2016 - 01/2016)
|
Related Diseases
Related Drugs and Biologics
Related Therapies and Procedures